Literature DB >> 31274538

Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV.

Deborah Kacanek1,2, Yanling Huo1,2, Kathleen Malee3, Claude A Mellins4, Renee Smith5, Patricia A Garvie6, Katherine Tassiopoulos7, Sonia Lee8, Claire A Berman7, Mary Paul9, Ana Puga6, Susannah Allison10.   

Abstract

OBJECTIVE: To identify factors associated with nonadherence and unsuppressed viral load across adolescence among youth with perinatally acquired HIV.
DESIGN: Longitudinal study at 15 US clinical sites.
METHODS: Self-reported antiretroviral medication nonadherence (any missed dose, past week) and unsuppressed viral load (HIV RNA > 400 copies/ml) were assessed annually. Individual, caregiver, social, and structural factors associated with nonadherence and unsuppressed viral load were identified by age (years): 8-11 (preadolescence), 12-14 (early adolescence), 15-17 (middle adolescence), and 18-22 (late adolescence/young adulthood), utilizing multivariable generalized linear mixed effects models.
RESULTS: During a median 3.3-year follow-up, 381 youth with perinatally acquired HIV contributed viral load measurements and 379 completed 1190 adherence evaluations. From preadolescence to late adolescence/young adulthood, prevalence of nonadherence increased from 31 to 50% (P < 0.001); prevalence of unsuppressed viral load increased from 16 to 40% (P < 0.001). In adjusted analyses, in pre, middle, and late adolescence/young adulthood, perceived antiretroviral side effects were associated with nonadherence. Additional factors associated with nonadherence included: in preadolescence, using a buddy system (as an adherence reminder); in early adolescence, identifying as black, using buddy system; in middle adolescence, CD4% less than 15%, unmarried caregiver, indirect exposure to violence, stigma/fear of inadvertent disclosure, stressful life events. Associations with unsuppressed viral load included: in early adolescence, youth unawareness of HIV status, lower income; in middle adolescence, perceived antiretroviral side effects, lower income; in late adolescence/young adulthood, distressing physical symptoms, and perceived antiretroviral side effects.
CONCLUSION: Prevalence of nonadherence and unsuppressed viral load increased with age. Associated factors varied across adolescence. Recognition of age-specific factors is important when considering strategies to support adherence.

Entities:  

Year:  2019        PMID: 31274538      PMCID: PMC6776473          DOI: 10.1097/QAD.0000000000002301

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  45 in total

1.  Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.

Authors:  David R Bangsberg
Journal:  Clin Infect Dis       Date:  2006-08-23       Impact factor: 9.079

2.  Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

Authors:  Russell B Van Dyke; Kunjal Patel; Ron M Kagan; Brad Karalius; Shirley Traite; William A Meyer; Katherine K Tassiopoulos; George R Seage; Lorna M Seybolt; Sandra Burchett; Rohan Hazra; Robert H Lurie; Ram Yogev; Margaret Ann Sanders; Kathleen Malee; Scott Hunter; William Shearer; Mary Paul; Norma Cooper; Lynnette Harris; Murli Purswani; Mahboobullah Baig; Anna Cintron; Ana Puga; Sandra Navarro; Patricia Garvie; James Blood; Sandra Burchett; Nancy Karthas; Betsy Kammerer; Andrew Wiznia; Marlene Burey; Molly Nozyce; Arry Dieudonne; Linda Bettica; Susan Adubato; Janet Chen; Maria Garcia Bulkley; Latreaca Ivey; Mitzie Grant; Katherine Knapp; Kim Allison; Megan Wilkins; Midnela Acevedo-Flores; Heida Rios; Vivian Olivera; Margarita Silio; Medea Jones; Patricia Sirois; Stephen Spector; Kim Norris; Sharon Nichols; Elizabeth McFarland; Alisa Katai; Jennifer Dunn; Suzanne Paul; Gwendolyn Scott; Patricia Bryan; Elizabeth Willen
Journal:  Clin Infect Dis       Date:  2016-04-07       Impact factor: 9.079

3.  Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.

Authors:  Shoshana Y Kahana; Maria Isabel Fernandez; Patrick A Wilson; Jose A Bauermeister; Sonia Lee; Craig M Wilson; Lisa B Hightow-Weidman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-01       Impact factor: 3.731

4.  Adapting Evidence-Based Interventions to Meet the Needs of Adolescents Growing Up with HIV in South Africa: The VUKA Case Example.

Authors:  Claude Ann Mellins; Danielle Nestadt; Arvin Bhana; Inge Petersen; Elaine J Abrams; Stacey Alicea; Helga Holst; Nonhlahla Myeza; Sally John; Latoya Small; Mary McKay
Journal:  Glob Soc Welf       Date:  2014-09

Review 5.  The effects of family and community violence on children.

Authors:  G Margolin; E B Gordis
Journal:  Annu Rev Psychol       Date:  2000       Impact factor: 24.137

6.  Changes in Advanced Immunosuppression and Detectable HIV Viremia Among Perinatally HIV-Infected Youth in the Multisite United States HIV Research Network.

Authors:  Allison L Agwu; John A Fleishman; Richard Rutstein; P Todd Korthuis; Kelly Gebo
Journal:  J Pediatric Infect Dis Soc       Date:  2013-03-12       Impact factor: 3.164

7.  The VUKA family program: piloting a family-based psychosocial intervention to promote health and mental health among HIV infected early adolescents in South Africa.

Authors:  Arvin Bhana; Claude A Mellins; Inge Petersen; Stacey Alicea; Nonhlahla Myeza; Helga Holst; Elaine Abrams; Sally John; Meera Chhagan; Danielle F Nestadt; Cheng-Shiun Leu; Mary McKay
Journal:  AIDS Care       Date:  2013-06-14

8.  The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.

Authors:  Kathleen Malee; Paige L Williams; Grace Montepiedra; Sharon Nichols; Patricia A Sirois; Deborah Storm; John Farley; Betsy Kammerer
Journal:  J Pediatr Psychol       Date:  2008-07-22

9.  Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.

Authors:  Jessica E Haberer; Lora Sabin; K Rivet Amico; Catherine Orrell; Omar Galárraga; Alexander C Tsai; Rachel C Vreeman; Ira Wilson; Nadia A Sam-Agudu; Terrence F Blaschke; Bernard Vrijens; Claude A Mellins; Robert H Remien; Sheri D Weiser; Elizabeth Lowenthal; Michael J Stirratt; Papa Salif Sow; Bruce Thomas; Nathan Ford; Edward Mills; Richard Lester; Jean B Nachega; Bosco Mwebesa Bwana; Fred Ssewamala; Lawrence Mbuagbaw; Paula Munderi; Elvin Geng; David R Bangsberg
Journal:  J Int AIDS Soc       Date:  2017-03-22       Impact factor: 5.396

10.  Multitype violence exposures and adolescent antiretroviral nonadherence in South Africa.

Authors:  Lucie Cluver; Franziska Meinck; Elona Toska; F Mark Orkin; Rebecca Hodes; Lorraine Sherr
Journal:  AIDS       Date:  2018-05-15       Impact factor: 4.177

View more
  7 in total

1.  Antiretroviral Therapy in Children and Adolescents: A Look Into Modern Single Tablet Regimens.

Authors:  Clara Lee; Jenna Sapasap; Joseph LaRochelle; Renata O Smith; Melissa E Badowski
Journal:  J Pediatr Pharmacol Ther       Date:  2021-11-10

2.  Randomized Controlled Trial of a Remote Coaching mHealth Adherence Intervention in Youth Living with HIV.

Authors:  K Rivet Amico; Jane C Lindsey; Michael Hudgens; Ronald Dallas; Keith J Horvath; Amanda Dunlap; Rachel Goolsby; Megan Mueller Johnson; Barbara Heckman; Jessica Crawford; Elizabeth Secord; Murli Purswani; Danial Reirden; Mobeen Rathore; Lisa-Gaye Robinson; Aditya H Gaur
Journal:  AIDS Behav       Date:  2022-06-07

3.  Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral load.

Authors:  Nadia Nguyen; C Jean Choi; Reuben Robbins; Rehema Korich; Jeanette Raymond; Curtis Dolezal; Cheng-Shiun Leu; Andrew Wiznia; Elaine J Abrams; Claude A Mellins
Journal:  AIDS       Date:  2020-07-01       Impact factor: 4.177

4.  Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement Intervention.

Authors:  K Rivet Amico; Jessica Crawford; Ini Ubong; Jane C Lindsey; Aditya H Gaur; Keith Horvath; Rachel Goolsby; Megan Mueller Johnson; Ronald Dallas; Barbara Heckman; Teresa Filipowicz; Melissa Polier; Betty M Rupp; Michael Hudgens
Journal:  AIDS Patient Care STDS       Date:  2021-05       Impact factor: 5.078

5.  Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors.

Authors:  Dwight E Yin; Christina Ludema; Stephen R Cole; Carol E Golin; William C Miller; Meredith G Warshaw; Ross E McKinney
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

Review 6.  Influence of Material Deprivation on Clinical Outcomes Among People Living with HIV in High-Income Countries: A Systematic Review and Meta-analysis.

Authors:  Vasiliki Papageorgiou; Bethan Davies; Emily Cooper; Ariana Singer; Helen Ward
Journal:  AIDS Behav       Date:  2021-12-11

7.  Factors Associated With Nonadherence to Antiretroviral Therapy Among Young People Living With Perinatally Acquired HIV in England.

Authors:  Ali Judd; Diane Melvin; Lindsay C Thompson; Caroline Foster; Marthe Le Prevost; Michael Evangeli; Alan Winston; Alejandro Arenas-Pinto; Kate Sturgeon; Katie Rowson; Diana M Gibb; Hannah Castro
Journal:  J Assoc Nurses AIDS Care       Date:  2020 Sep-Oct       Impact factor: 1.354

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.